Document is current
Any future updates will be listed below
-
Authors
Woerman, Amanda L.
Oehler, Abby
Kazmi, Sabeen A.
Lee, Jisoo
Halliday, Glenda M.
Middleton, Lefkos T.
Gentleman, Steve M.
Mordes, Daniel A.
Spina, Salvatore
Grinberg, Lea T.
Olson, Steven H.
Prusiner, Stanley B. https://orcid.org/0000-0003-1955-5498
-
Funding
Funding for this research was provided by:
National Institute on Aging (AG002132)
National Institute on Aging (AG031220)
Glenn Foundation for Medical Research
Daiichi-Sankyo
- License Information
-
More Information
Article History
Received: 12 December 2018
Revised: 8 January 2019
Accepted: 9 January 2019
First Online: 28 January 2019
Compliance with ethical standards
:
: The Institute for Neurodegenerative Diseases has a research collaboration with Daiichi Sankyo (Tokyo, Japan). S.B.P. is the chair of the Scientific Advisory Board of Alzheon, Inc., and a member of the Scientific Advisory Board of ViewPoint Therapeutics, neither of which has contributed financial or any other support to these studies.
: Animals were maintained in an AAALAC-accredited facility in compliance with the <i>Guide for the Care and Use of Laboratory Animals</i>. All procedures used in this study were approved by the University of California, San Francisco, Institutional Animal Care and Use Committee.
